Clinical Trial Update: Phase II Study on Axitinib in Advanced Solitary Fibrous Tumor [Phase 2]

View source ↗

Summary

Phase II study evaluating axitinib in advanced solitary fibrous tumor has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solitary Fibrous Tumor

Drugs mentioned

• Axitinib (Axitinib)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Solitary Fibrous Tumor | Phase 2 | Status: COMPLETED